Role of PRAS40 in Akt and mTOR signaling in health and disease
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
The proline-rich Akt substrate of 40 kDa (PRAS40) acts at the intersection of the Akt- and mammalian target of rapamycin (mTOR)-mediated signaling pathways. The protein kinase mTOR is the catalytic subunit of two distinct signaling complexes, mTOR complex 1 (mTORC1) and mTORC2, that link energy and nutrients to the regulation of cellular growth and energy metabolism. Activation of mTOR in response to nutrients and growth factors results in the phosphorylation of numerous substrates, including the phosphorylations of S6 kinase by mTORC1 and Akt by mTORC2. Alterations in Akt and mTOR activity have been linked to the progression of multiple diseases such as cancer and type 2 diabetes. Although PRAS40 was first reported as substrate for Akt, investigations toward mTOR-binding partners subsequently identified PRAS40 as both component and substrate of mTORC1. Phosphorylation of PRAS40 by Akt and by mTORC1 itself results in dissociation of PRAS40 from mTORC1 and may relieve an inhibitory constraint on mTORC1 activity. Adding to the complexity is that gene silencing studies indicate that PRAS40 is also necessary for the activity of the mTORC1 complex. This review summarizes the regulation and potential function(s) of PRAS40 in the complex Akt- and mTOR-signaling network in health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 10×
“and direction of the subcellular localization (61).”
BackgroundInfluentialCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 7×
“This leads to tyrosine phosphorylation and activation of the insulin receptor itself and of multiple substrates, such as the insulin receptor substrate (IRS) proteins (47).”
BackgroundInfluentialLarge-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil, S. A., Jedrychowski, M., Schwartz, D., Elias, J. E., Villén, J., Li, J., Cohn, M. A., Cantley, L. C., & Gygi, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404720101 · Cited by 1,375 · cited 2×
“The tyrosine-phosphorylated IRS proteins recruit PI3K to the plasma membrane, where activated PI3K phosphorylates phosphatidylinositol-4,5-biphosphate to form phosphatidylinositol-3,4,5-triphosphate [PI(3,4,5)P3] (47).”
BackgroundRegulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
Sengupta, S., Peterson, T. R., & Sabatini, D. M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.026 · Cited by 1,241 · cited 2×
“These multiple aspects of mTORC1- and mTORC2-signaling pathways have been reviewed extensively by others (29, 45, 61).”
BackgroundPRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · cited 7×
“In Xenopus laevis, Danio rerio and Drosophila melanogaster proteins, which are identical to the carboxy-terminal part of human PRAS40 but lack entirely the proline-enriched stretches found in the amino-terminal PRAS40 proteins from higher species, have been found (33, 37, 42).”
BackgroundInfluentialInsulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D.-H. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,190 · cited 10×
“In 3T3L1 adipocytes and HepG2 cells, silencing PRAS40 resulted in a decreased insulin-mediated phosphorylation of Akt (51).”
BackgroundInfluentialHsu, P. P., Kang, S. A., Rameseder, J., Zhang, Y., Ottina, K. A., Lim, D., Peterson, T. R., Choi, Y., Gray, N. S., Yaffe, M. B., et al. (2011) · Science · doi:10.1126/science.1199498 · Cited by 1,084 · cited 10×
“In another report, Torin-1 downregulated the phosphorylation of Ser(183), Thr(246), Ser(202), and Ser(212) in wild-type embryonic fibroblasts, but upregulation of these phosphorylation sites in cells lacking TSC2 could not be confirmed (20).”
BackgroundInfluentialYu, Y., Yoon, S.-O., Poulogiannis, G., Yang, Q., Ma, X. M., Villén, J., Kubica, N., Hoffman, G. R., Cantley, L. C., Gygi, S. P., et al. (2011) · Science · doi:10.1126/science.1199484 · Cited by 854 · cited 8×
“Finally, phosphorylation of PRAS40 on multiple residues, including Ser(88), Ser(92), Ser(116), Ser(183), Thr(198), Ser(202), Ser(203), Ser(211), Ser(212), Ser(221), and Thr(246), has been reported (9, 20, 28, 35, 53, 59).”
BackgroundInfluentialAn Emerging Role of mTOR in Lipid Biosynthesis
Laplante, M., & Sabatini, D. M. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.058 · Cited by 620 · cited 1×
“These multiple aspects of mTORC1- and mTORC2-signaling pathways have been reviewed extensively by others (29, 45, 61).”
Background
Cited by
Schulte, M. L., Fu, A., Zhao, P., Li, J., Geng, L., Smith, S. T., Kondo, J., Coffey, R. J., Johnson, M. O., Rathmell, J. C., et al. (2018) · Nature Medicine · doi:10.1038/nm.4464 · Cited by 494
The critical role of Akt in cardiovascular function
Abeyrathna, P., & Su, Y. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.05.008 · Cited by 423
mTOR in Brain Physiology and Pathologies
Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 356
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Joosten, L. A. B., Crişan, T. O., Bjornstad, P., & Johnson, R. J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0334-3 · Cited by 319
Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Cabău, G., Crișan, T. O., Klück, V., Popp, R. A., & Joosten, L. A. B. (2020) · Immunological Reviews · doi:10.1111/imr.12833 · Cited by 261
Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass
Goodman, C. A. (2019) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01011.2018 · Cited by 133
Bond, P. (2016) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-016-0118-y · Cited by 121
“PRAS40 is phosphorylated at one threonine residue (Thr246) and two serine residues (Ser181 and Ser221) [31].”
BackgroundFrancaux, M., Demeulder, B., Naslain, D., Fortin, R., Lutz, O., Caty, G., & Deldicque, L. (2016) · Nutrients · doi:10.3390/nu8010047 · Cited by 83
“After a blocking step of 1 h, membranes were probed with the following primary antibodies overnight: phospho-Thr389 S6K1, phospho-Ser2448 mTOR, phospho-Thr246 proline-rich Akt substrate of 40 kDa (PRAS40), phospho-Ser473 Akt/protein kinase B (Akt/PKB), phospho-Thr308 Akt/PKB, phospho-Thr172 AMPK, phospho-Ser79 Acetyl…”
BackgroundInfluentialUrsolic acid stimulates mTORC1 signaling after resistance exercise in rat skeletal muscle
Ogasawara, R., Sato, K., Higashida, K., Nakazato, K., & Fujita, S. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00302.2013 · Cited by 70
Metadata
- Authors
- Wiza, C., Nascimento, E. B. M., & Ouwens, D. M.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2012-06-15
- Volume
- 302
- Issue
- 12
- Pages
- E1453-E1460
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2115896420
- Cited by
- 177
- References
- 61
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.